PacificGMP, a CMO, has doubled its GMP production capacity with the addition of a second System 1000 Bioreactor platform from GE Healthcare. This second System 1000, with a 500 L working volume, increases PacificGMP’s large scale GMP production capacity to 1000 L for fed and fed-batch production. In addition, it provides an additional 15,000 L of production capacity when run in perfusion mode. The addition provides PacificGMP a total perfusion capacity of 30,000 L.
Expansion of its operational capacity will allow PacificGMP to increase its large scale clinical manufacturing projects for its research clients, customers, and partners.